IDiyas

For the Inventor, By the Inventor

West Caldwell, NJ, United States of America

Christopher Self

USPTO Granted Patents = 23

 

Average Co-Inventor Count = 4.9

ph-index = 7

Forward Citations = 324(Granted Patents)


Location History:

  • West Caldwell, NJ (US) (1999 - 2016)
  • Monmouth Junction, NJ (US) (2016 - 2017)

Company Filing History:

goldMedal11 out of 43 
 
Praecis Pharmaceuticals, Inc.
 patents
silverMedal6 out of 6 
 
Provid Pharmaceuticals Inc.
 patents
bronzeMedal2 out of 1,454 
 
Rutgers, the State University of New Jersey
 patents
4. 2 out of 2 
 
Immune Control Inc.
 patents
5. 2 out of 3,435 
 
National Institutes of Health, a Component of the US Dept. of Health & Human Services
 patents
6. 1 out of 186 
 
Sequenom, Inc.
 patents
7. 1 out of 15,458 
 
University of California
 patents
8. 1 out of 14 
 
Cognosci, Incorporated
 patents
9. 1 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents
where one patent can have more than one assignee

Years Active: 1999-2017

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents
1. 9592221 - Antibacterial agents: aryl myxopyronin derivatives (2017-03-14),
2. 9315495 - Antibacterial agents: aryl myxopyronin derivatives (2016-04-19),
3. 9278089 - Method of treating HCV infection with a small molecule CHK2 inhibitor (2016-03-08),
4. 8765802 - Kinase inhibitors, compositions thereof, and methods of use therewith (2014-07-01),
5. 8598312 - Inhibitors of antigen presentation by MHC class II molecules (2013-12-03),
6. 8222215 - Methods for the use of inhibitors of antigen presentation by MHC class II molecules (2012-07-17),
7. 7981885 - Compositions for treatment of diseases related to activated lymphocytes (2011-07-19),
8. 7947645 - APO E analogs and methods for their use (2011-05-24),
9. 7923445 - Methods for treatment of diseases related to activated lymphocytes (2011-04-12),
10. 7803774 - Modulators of β-amyloid peptide aggregation (2010-09-28),
11. 7439231 - Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof (2008-10-21),
12. 7432342 - Kinase anchor protein muteins, peptides thereof and related documents (2008-10-07),
13. 7405194 - Therapeutic agents and methods of use thereof for the treatment of melanoma (2008-07-29),
14. 7348307 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2008-03-25),
15. 7268111 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-09-11),

Title: The Innovative Mind of Christopher Self

Introduction: Christopher Self, a talented inventor hailing from West Caldwell, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Christopher Self holds several patents in the field of renewable energy technologies, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the industry, Christopher Self has worked for top renewable energy companies, leading research and development teams to create cutting-edge solutions for a sustainable future.

Collaborations: Throughout his career, Christopher Self has collaborated with renowned scientists and engineers from prestigious universities and research institutions, fostering a culture of innovation and excellence in every project.

Conclusion: Christopher Self's passion for innovation and his dedication to creating a greener world through technology make him a true pioneer in the field of renewable energy. His inventive spirit continues to inspire the next generation of inventors and engineers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…